Electrophysiology News and Research

RSS

Advances in leadless pacing: an interview with Dr. Reddy

Pacemakers have been around for a very long time, they're great devices, critical for many people who have slow heartbeats. While they're very effective, they have some issues. There are two main aspects relating to these issues.

1 Dec 2015

The American Heart Association and Heart Rhythm Society Unite to Improve Cardiovascular Research, Care

The American Heart Association and Heart Rhythm Society today announced a collaboration designed to advance research and improve the delivery of care for people with an irregular heartbeat known as atrial fibrillation (AFib).

20 Oct 2015

Mayo Clinic researchers awarded NIH grant to develop intelligent devices to track and treat epilepsy

Researchers at Mayo Clinic were awarded a $6.8 million, five-year federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.

7 Oct 2015

NYSCF, Q-State partner to advance precision medicine for nervous system disorders

The New York Stem Cell Foundation and Q-State Biosciences are partnering in a joint research collaboration to advance patient care for nervous system disorders through precision medicine. Through this collaboration, both organizations will further advance their respective technologies, while exploring how their proprietary research platforms might provide synergies in the process of developing novel therapeutics and companion diagnostics.

21 Sep 2015

LEADLESS II study confirms positive benefits of St. Jude Medical’s Nanostim leadless pacemaker

St. Jude Medical, Inc., a global medical device company, today announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim™ leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.

3 Sep 2015

Boston Scientific receives CE Mark on MRI conditional labeling for CRT-D and ICD systems

Boston Scientific Corporation has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and MINI implantable cardioverter defibrillator (ICD) and the X4 cardiac resynchronization therapy defibrillator (CRT-D) systems. This revised labeling ensures that future patients and those already implanted with these systems are able to undergo MRI scans if indicated.

25 Aug 2015

WATCHMAN Device helps reduce stroke risk, stop use of blood thinners in patients with atrial fibrillation

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib).

3 Jul 2015

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe, reveals research presented today at EHRA EUROPACE - CARDIOSTIM 2015 by Dr Carsten Wunderlich, senior consultant in the Department of Invasive Electrophysiology, Heart Centre Dresden, Germany.

25 Jun 2015

UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

The current monitoring of patients with cardiac implantable electronic devices (CIEDs) such as pacemakers and defibrillators may be underestimating device problems, according to UC San Francisco researchers who propose systematic methods to determine accurate causes of sudden death in those with CIEDs as well as improved monitoring for device concerns.

23 Jun 2015

Research: Patients test drive pacemaker outside the skin before deciding on permanent implant

Patients are test driving a pacemaker outside the skin before deciding whether to have a permanent implant, reveals novel research presented today at EHRA EUROPACE - CARDIOSTIM 2015 by Professor Michael Giudici, director of arrhythmia services in the Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, US.

22 Jun 2015

Cardiac device wearers ought to keep safe distance from smartphones to prevent unwanted painful shocks

Cardiac device wearers should keep a safe distance from smartphones to avoid unwanted painful shocks or pauses in function, reveals research presented today at EHRA EUROPACE -- CARDIOSTIM 2015 by Dr. Carsten Lennerz, first author and cardiology resident in the Clinic for Heart and Circulatory Diseases, German Heart Centre, Munich, Germany.

22 Jun 2015

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.

19 Jun 2015

New Cedars-Sinai study identifies unique set of neurons involved in memory-based decision making

The witness on the stand says he saw the accused at the scene of the crime. Is he sure? How sure? The jury's verdict could hinge on that level of certainty. Many decisions we make every day are influenced by our memories and the confidence we have in them. But very little is known about how we decide whether we can trust a memory or not.

10 Jun 2015

Unfors RaySafe launches LowerMyDose.com to educate physicians, clinical staff on radiation exposure risks

For years, the radiology industry has focused on reducing, or eliminating patient exposure to radiation. Recently, the industry has shifted attention to the cumulative effect radiation exposure has over the course of a physician's career.

3 Jun 2015

Brain protein plays key role in controlling binge drinking

Scientists at The Scripps Research Institute have discovered that a brain protein has a key role in controlling binge drinking in animal models. They found that deleting the gene for this protein in mice ramped up alcohol consumption and prevented the brain from signaling the rewarding properties of alcohol.

12 May 2015

CPAP use reduces atrial fibrillation recurrence in patients with obstructive sleep apnea

The use of continuous positive airway pressure was associated with a significant reduction in the recurrence of atrial fibrillation in patients with obstructive sleep apnea, according to an analysis of data from past research published today in the Journal of the American College of Cardiology: Clinical Electrophysiology.

21 Apr 2015

MHIF investigator performs first atrial fibrillation ablation in U.S. using SMARTTOUCH SF catheter

Dr. Daniel Melby, an investigator at the Minneapolis Heart Institute Foundation, performed the first atrial fibrillation ablation in the U.S. using Biosense Webster's new THERMOCOOL SMARTTOUCH SF contact force sensing catheter as part of an FDA regulated safety trial (SMART-SF).

1 Apr 2015

Boston Scientific announces successful implantations of WATCHMAN Device in three US patients

This week, three patients in the United States received the first implants of the Boston Scientific Corporation WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device.

25 Mar 2015

Study tracks long-term effects of weight loss on atrial fibrillation burden

Obese patients with atrial fibrillation who lost at least 10 percent of their body weight were six times more likely to achieve long-term freedom from this common heart rhythm disorder compared to those who did not lose weight, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.

17 Mar 2015

Neuronetrix announces FDA approval of COGNISION System for clinical use

Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION System for clinical use.

21 Feb 2015